Morgan Stanley Amends abrdn Healthcare Investors (HQH) Stake
Ticker: HQH · Form: SC 13G/A · Filed: Feb 12, 2024 · CIK: 805267
| Field | Detail |
|---|---|
| Company | Abrdn Healthcare Investors (HQH) |
| Form Type | SC 13G/A |
| Filed Date | Feb 12, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
Related Tickers: HQH
TL;DR
**Morgan Stanley updated its passive stake in abrdn Healthcare Investors (HQH) as of year-end 2023.**
AI Summary
Morgan Stanley filed an amended Schedule 13G/A on February 12, 2024, indicating its ownership of abrdn Healthcare Investors (HQH) common stock as of December 31, 2023. This is the 14th amendment to their filing, showing a continued, though potentially adjusted, passive investment in the healthcare-focused closed-end fund. This matters to investors because Morgan Stanley is a major institutional investor, and their holdings can signal confidence or changes in sentiment towards HQH, potentially influencing other investors' decisions.
Why It Matters
This filing updates Morgan Stanley's passive ownership in abrdn Healthcare Investors, providing transparency on a significant institutional holder's position, which can influence market perception and trading activity for HQH.
Risk Assessment
Risk Level: low — This is a routine amendment by a large institutional investor, indicating passive ownership, which typically carries low immediate risk.
Analyst Insight
Investors should note Morgan Stanley's continued presence as a passive holder in abrdn Healthcare Investors, but without specific changes in ownership percentage or intent, this filing primarily serves as an update rather than a signal for immediate action.
Key Players & Entities
- Morgan Stanley (company) — the entity filing the SC 13G/A, reporting its ownership
- abrdn Healthcare Investors (company) — the issuer whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- February 12, 2024 (date) — the date the SC 13G/A was filed
- 87911J103 (other) — the CUSIP number for abrdn Healthcare Investors common stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Amendment No.14)*' sections.
Who is the reporting person in this filing?
The reporting person is Morgan Stanley, as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MORGAN STANLEY' section.
What is the subject company (issuer) of the securities being reported?
The subject company is abrdn Healthcare Investors, as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: abrdn Healthcare Investors' and 'Name of Issuer: abrdn Healthcare Investors'.
What was the 'Date Of Event which Requires Filing of this Statement'?
The date of the event requiring this filing was December 31, 2023, as explicitly stated in the filing.
How many amendments has Morgan Stanley filed for this specific Schedule 13G regarding abrdn Healthcare Investors?
This is the 14th amendment, as indicated by '(Amendment No.14)*' on the cover page of the Schedule 13G.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 12, 2024 regarding abrdn Healthcare Investors (HQH).